PRT120
/ Prota Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 09, 2022
Prota Therapeutics Achieves Peanut Allergy Treatment Milestone: Groundbreaking Clinical Trial Data Demonstrates Clinical Remission of Peanut Allergy in Paediatric Patients
(PRNewswire)
- "Prota Therapeutics....Published in The Lancet Child & Adolescent Health...the Phase 2b clinical trial results validate Prota's lead product candidate PRT120...The placebo-controlled trial confirms the effectiveness of PRT120 comprising Prota's rapid escalation dosing regimen in inducing clinical remission of peanut allergy in children and improving quality of life for patients....Prota Therapeutics is looking to raise funds to support the further clinical development and commercialization of PRT120."
P2b data • Food Hypersensitivity
1 to 1
Of
1
Go to page
1